Shares of Arena Pharmaceuticals rose 3.6% to $66.15 at 15:05 EST on Thursday. The Nasdaq Stock Market is jumping 0.59% to $11871.7, on what seems, as yet, an all-around positive trading session on The Nasdaq Stock Market.
Arena Pharmaceuticals’s last close was $63.85, below its 52-week high of $90.19.
Arena Pharmaceuticals’s sales growth is negative 81.3% for the current quarter and 155.7% for the next. The company’s growth estimates for the present quarter and the next is a negative 8% and a positive 4.5%, respectively.
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals’s stock is valued at $66.15 at 15:05 EST, way under its 52-week high of $90.19 and way higher than its 52-week low of $32.95.
Arena Pharmaceuticals’s worth is way below its 50 day moving average of $78.72 and under its 200 day moving average of $67.41.